Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03511586 · ClinicalTrials.gov registry record

Total Shoulder Arthroplasty Multi-Center Registry

A clinical trial of Shoulder Arthroplasty, sponsored by Arthrex.

Recruiting
Registry status
2,500
Enrollment target
20
Study locations

NCT03511586: Recruiting study of Shoulder Arthroplasty, sponsored by Arthrex.

NCT03511586 is a study of Shoulder Arthroplasty that is actively recruiting participants, run by Arthrex. The registered enrollment target is 2,500 participants, above the 606-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (313% higher). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03511586, a study of Shoulder Arthroplasty, is actively recruiting participants, sponsored by Arthrex.

RECRUITING
Registry status
2,500 participants
Enrollment target
20
Study locations

Study Summary

The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.

Primary Outcome

Measure of pain intensity. This is done with the Visual Analog Scare. (VAS)

Conditions Studied

Study Locations (20)

Arizona

  • University of Arizona/Banner Health - Phoenix
  • Banner Medical Group - Phoenix
  • - Scottsdale

Florida

  • Andrews Research & Education Foundation - Gulf Breeze
  • Advent Health Orlando - Orlando

Michigan

  • The University of Michigan - Ann Arbor
  • - Grand Rapids

North Carolina

  • University of North Carolina - Chapel Hill
  • Wake Forest University Health Sciences - Winston-Salem

Colorado

  • - Denver

Connecticut

  • University of Connecticut Health Center - Farmington

Illinois

  • NorthShore University Health System - Evanston

Indiana

  • The Trustees of Indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2015-07-28
Est. Completion 2035-11
Arthrex

12 total trials

What NCT03511586 shows while recruiting

NCT03511586 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 606-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (313% higher).

The record links to 1 condition, with Shoulder Arthroplasty appearing as the primary indexed condition, and to 0 interventions.

NCT03511586 names 20 study sites across 15 states, led by Arizona, Florida, Michigan.

Frequently Asked Questions

What is clinical trial NCT03511586 about?

NCT03511586 is a clinical study titled "Total Shoulder Arthroplasty Multi-Center Registry". The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.

What is the current status of trial NCT03511586?

This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2015-07-28. Estimated completion is 2035-11.

What conditions does trial NCT03511586 study?

This clinical trial studies the following conditions: Shoulder Arthroplasty.

Who is sponsoring clinical trial NCT03511586?

This trial is sponsored by Arthrex, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03511586 being conducted?

This trial has 20 study locations across Arizona, Colorado, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03511586, the US trial registry maintained by the National Library of Medicine. NCT03511586 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.